Yahoo Web Search

Search results

1. • Exercise bouts could improve efficacy of cancer drug

     Medical Xpress· 5 hours ago

     Researchers at the Universities of Birmingham and Bath found that a bout of exercise increased the number of anti-cancer immune cells—called natural killer cells—and that these cells were around ...

2. • Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma

     Morningstar· 6 days ago

     Breyanzi, which was already approved in the U.S. for the treatment of relapsed or refractory large B-cell lymphoma after at least one line of therapy and for relapsed or refractory ...

3. • 

     Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion

     Zacks via Yahoo Finance· 5 days ago

     Bristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...

4. • 

     Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY

     Zacks via Yahoo Finance· 5 days ago

     The therapy was also granted accelerated approval for the treatment of relapsed or refractory ...

5. • Q1 2024 Bio Path Holdings Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

     Venetoclax has shown activity against the [anti-up total] protein Bcl-2 and works by neutralizing the protein's BH-3 domain. It is an approved treatment for chronic

6. • Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration...

     Morningstar· 6 days ago

     Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma 95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical

7. • 

     Keeping CAR T Cells Sharp

     The Scientist· 17 hours ago

     Chimeric antigen receptor (CAR) T cells have a tough job. Engineered with a receptor that recognizes molecules decorating the surface of cancer cells,...

8. • 

     GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market

     NewMediaWire via Yahoo Finance· 5 days ago

     ATLANTA, GA - (NewMediaWire) - May 17, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage...

9. • 

     What Is Immunophenotyping?

     Healthline· 6 days ago

     Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases....

10. • The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below...

      Nature· 5 days ago

      Detection of measurable residual disease (MRD) in hematological malignancies is crucial for prognostication and treatment decisions. Real-time quantitative PCR (RQ-PCR), which targets immunoglobulin ...